Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 133550-37-5 |
MDL number | MFCD00209855 |
Molecular weight | 308.34 |
Molecular Formula | C18H16N2O3 |
Product code | ICTT3540 |
PubChem Substance ID | 354334648 |
Purity/Analytical Methods | >98.0%(HPLC) |
Reaxys-RN | 4356230 |
Situations to avoid | Light Sensitive,Air Sensitive,Heat Sensitive |
Store under inert gas | Store under inert gas |
Appearance | Light yellow to Amber to Dark green powder to crystal |
---|
Pictograms | |
---|---|
Hazard statement | H371 : May cause damage to organs H373 : May cause damage to organs through prolonged or repeated exposure. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray P270 : Do not eat, drink or smoke when using this product P264 : Wash skin thoroughly after handling P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor P405 : Store locked up. |
Signal word | Warning |
Life Science Biochemicals and Reagents Enzymes, Enzyme Inhibitors, Enzyme Substrates Enzyme Inhibitors [Biochemicals and Reagents] Enzyme Inhibitors [P to Q] Protein Kinase Inhibitors, Tyrosine Enzyme Inhibitors by Enzyme Other Bioactive Small Molecules Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Other Antitumor Ingredients (for Research and Experimental Use) Cell Biology Cancer Research Antitumor Agents Receptor Tyrosine Kinase (RTK) Inhibitors Epidermal Growth Factor Receptor (EGFR) Family Kinase Inhibitors Tyrosine Kinase Inhibitors [Antitumor Agents] Cell Signaling and Neuroscience Kinase/Phosphatase Biology Epidermal Growth Factor Receptor (EGFR) Family Kinase Inhibitors Receptor Tyrosine Kinase (RTK) Inhibitors Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Other Antitumor Ingredients (for Research and Experimental Use)